This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Waters (WAT) Q3 Earnings Preview: What to Watch Ahead of the Release
by Zacks Equity Research
Waters (WAT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Waters Corp (WAT) Q2 Earnings Beat, Revenues Lag Estimates
by Zacks Equity Research
Waters Corp (WAT) witnesses year-over-year improvement in both earnings and revenues in second-quarter quarter results.
Waters (WAT) Beats Q2 Earnings Estimates
by Zacks Equity Research
Waters (WAT) delivered earnings and revenue surprises of 1.56% and -0.30%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Waters Corp (WAT) Earnings Beat Estimates in Q2
by Zacks Equity Research
Waters Corp's (WAT) reported second quarter results wherein both earnings and revenues grew year over year.
What's in the Cards for Waters Corp (WAT) in Q2 Earnings?
by Zacks Equity Research
Waters Corp (WAT) is scheduled to report second-quarter results which are likely to be driven by its strong position in the pharmaceutical market and robust mass spectrometry portfolio.
Zacks Industry Outlook Highlights: Waters, Mettler-Toledo and PerkinElmer
by Zacks Equity Research
Zacks Industry Outlook Highlights: Waters, Mettler-Toledo and PerkinElmer
Instruments - Scientific Outlook: Growth Prospects Abound
by Aniruddha Ganguly
Instruments - Scientific industry's growth prospect is quite bright in the near term given rising spending by the government and academic labs.
Waters (WAT) Up 1.5% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Waters' (WAT) Q1 Earnings Beat, Revenues Miss Estimates
by Zacks Equity Research
Waters' (WAT) first-quarter results are driven by robust product portfolio and strong end-market performance.
Waters Corp (WAT) Earnings and Sales Beat Estimates in Q1
by Zacks Equity Research
Waters'(WAT) adjusted earnings from continuing operations of $1.59 per share beat the Zacks Consensus Estimate by four cents.
Why Earnings Season Could Be Great for Waters Corporation (WAT)
by Zacks Equity Research
Waters Corporation (WAT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Can Strong Memory Save Lam Research (LRCX) in Q3 Earnings?
by Zacks Equity Research
Lam Research's (LRCX) third-quarter results are likely to benefit from the strong memory market and shipments. However, volatility in the PC market remains a concern.
Why Is Waters Corporation (WAT) Down 4.7% Since its Last Earnings Report?
by Zacks Equity Research
Waters Corporation (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Waters' (WAT) Q4 Earnings Beat on Broad-Based Sales Growth
by Zacks Equity Research
Waters Corp.'s (WAT) fourth-quarter 2017 earnings beat driven by broad-based top-line expansion, along with spectacular growth in Europe.
Waters Corp. (WAT) Q4 Earnings, Revenues Beat Estimates
by Zacks Equity Research
Waters Corp. (WAT) fourth-quarter earnings beat estimates comfortably, and revenues grew year over year.
What's in the Offing for Waters Corp (WAT) in Q4 Earnings?
by Zacks Equity Research
High R&D and interest expenses are expected to hurt Waters Corp.'s (WAT) profitability in the quarter to be reported.
Here's Why Investing In Waters Corp (WAT) Now Makes Sense
by Zacks Equity Research
Steady demand from pharmaceutical business, solid recurring revenues and modest recovery in industrial markets are proving conducive to Waters Corp's (WAT) impressive performance.
Waters (WAT) Q2 Earnings Beat on Broad-Based Sales Growth
by Zacks Equity Research
Waters Corp's (WAT) third-quarter 2017 earnings beat was driven by broad-based top-line expansion, along with spectacular growth in Europe.
Waters Corp. (WAT) Q3 Earnings Beat Estimates, Sales Strong
by Zacks Equity Research
Waters Corp. (WAT) third-quarter earnings beat estimates comfortably, and revenues grew year over year.
Why Waters (WAT) Might Surprise This Earnings Season
by Zacks Equity Research
Waters (WAT) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
Why Waters Corp (WAT) Looks Set to Beat on Q3 Earnings
by Zacks Equity Research
Waters Corp (WAT) expects to beat third-quarter 2017 earnings on the back of steady demand from pharmaceutical business, growth in recurring revenues and modest recovery of industrial markets.
Why Is Waters (WAT) Down 2.1% Since the Last Earnings Report?
by Zacks Equity Research
Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Waters (WAT) Q2 Earnings Beat on Broad-Based Sales Growth
by Zacks Equity Research
Waters Corp. (WAT) second-quarter 2017 earnings beat was driven by broad-based top-line expansion, along with spectacular growth in Asia.
Waters Corp. (WAT) Q2 Earnings Beat Estimates, Sales Up Y/Y
by Zacks Equity Research
Waters Corp. (WAT) second-quarter earnings beat estimates comfortably, and revenues grew year over year.
Why Earnings Season Could Be Great for Waters Corporation (WAT)
by Zacks Equity Research
Investors might want to consider this stock ahead of earnings Given that Waters Corporation (WAT) has a Zacks Rank #2 (Buy) and an ESP in positive territory.